骏鼎达(301538) - 骏鼎达：投资者关系活动记录表（2025年6月20日）

Financial Performance - The company achieved a revenue of 865 million yuan in 2024, representing a year-on-year growth of 34.30% [2] - The net profit for 2024 was 176 million yuan, with a year-on-year increase of 26.01% [2] - In Q1 2025, the revenue reached 229 million yuan, showing a growth of 39.00% compared to the same period last year [2] - The net profit for Q1 2025 was 47 million yuan, an increase of 3.24% year-on-year [14] Revenue Sources - Revenue from the automotive sector accounted for 65.60% of total revenue in 2024 [3] - The medical sector generated nearly 3 million yuan in revenue in 2024, indicating growth from 2023, but still represents a low proportion of total revenue [4] - Sales revenue from the U.S. region was approximately 50.92 million yuan, making up 5.91% of the main business revenue in 2024 [7] Market Expansion and Strategy - The company is focusing on expanding into the medical industry, with a dedicated subsidiary that has obtained quality management system certification [4] - Plans for capacity enhancement include new production sites and potential investments in Morocco [5][9] - The company is exploring opportunities in emerging markets such as low-altitude economy and humanoid robots, with ongoing R&D efforts [11] Competitive Landscape - The industry is characterized by a fragmented competitive landscape, with numerous players ranging from multinational corporations to smaller domestic firms [10] - The company has established significant technical and qualification barriers, enhancing its competitive edge [6][7] Operational Insights - The total operational area of the main subsidiaries is approximately 115,000 square meters [5] - As of the end of 2024, the company employed 110 R&D personnel, accounting for 11.5% of the total workforce [12] - The first major customer contributed sales of approximately 154.24 million yuan, representing 17.84% of total annual sales [7] Future Outlook - The company is actively assessing the feasibility of establishing sales and production facilities in Southeast Asia [13] - There are plans to continue investor relations activities to maintain communication with stakeholders [14]